TD2 (Translational Drug Development)
Contract research organization (CRO) · United States
TD2 (Translational Drug Development) is a contract research organization (CRO) headquartered in United States.
td2inc.comProfile compiled from public records. Is this your company? Request a correction or update
TD2 (Translational Drug Development) at a glance
Typecontract research organization (CRO)
HeadquartersUnited States
TD2 (Translational Drug Development) on the BioBridgeX marketplace
CRO · In Vitro Pharmacology, Biomarker Discovery & Development, PK/PD & Modeling
Services
In Vitro PharmacologyBiomarker Discovery & DevelopmentPK/PD & ModelingClinical OperationsBiostatistics & Statistical ProgrammingMedical Writing
Therapeutic areas
OncologyHematology
Modalities
Small MoleculeMonoclonal Antibody (mAb)Bispecific / Multispecific AntibodyAntibody-Drug Conjugate (ADC)Cell Therapy (CAR-T / NK / TIL)
Unclaimed listing. Claim this profile
Frequently asked questions about TD2 (Translational Drug Development)
Where is TD2 (Translational Drug Development) headquartered?
TD2 (Translational Drug Development) is headquartered in United States.
What does TD2 (Translational Drug Development) do?
TD2 (Translational Drug Development) is a contract research organization (CRO).
Similar companies
- Champions OncologyBaltimore, Maryland, United States
- Twist BioscienceSouth San Francisco, California, United States
- InotivWest Lafayette, Indiana, United States
- CertaraRadnor, Pennsylvania, United States
- Reaction BiologyMalvern, Pennsylvania, United States
- Charles River LaboratoriesWilmington, Massachusetts, United States
- Simulations PlusLancaster, California, United States
- Crown BioscienceSanta Clara, California, United States
Sources
Last updated 2026-09-23.